Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
Zydus Life Sciences, an Indian pharmaceutical company, has reached a $120 million settlement agreement with Astellas Pharma Inc. to resolve ongoing patent litigation related to the bladder drug mirabegron. The settlement ends the dispute over patent rights in the United States, allowing both parties to avoid protracte…
Share This Article
Ready-to-post copy includes the article link.
Zydus Life Settles Patent Dispute with Astellas for $120 Million Over Bladder Medication Zydus Life Sciences, an Indian pharmaceutical company, has reached a $120 million settlement agreement with Astellas Pharma Inc. to resolve ongoing patent litigation related to the bladder drug mirabegron. The settlemen... Read the full IIPLA article: https://iipla.org/news/zydus-life-settles-patent-dispute-with-astellas-for-120-million-over-bladder-medication